💨 Abstract

Premas Life Sciences and Sphere Bio have announced a strategic partnership to bring advanced single-cell analysis technology to researchers in India and Bangladesh. Sphere Bio's Cyto-Mine® platform and assay portfolio will be made available, backed by local technical expertise and support. This move aims to accelerate scientific discovery in the biopharma, biotech, and academic sectors, driving impactful research.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖

Powered by MessengerX.io